Shopping Cart
- Remove All
- Your shopping cart is currently empty
1. Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties. 2. Methylophiopogonanone A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $72 | In Stock | |
5 mg | $168 | In Stock | |
10 mg | $250 | In Stock | |
25 mg | $418 | In Stock | |
50 mg | $623 | In Stock | |
100 mg | $887 | In Stock | |
1 mL x 10 mM (in DMSO) | $190 | In Stock |
Description | 1. Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties. 2. Methylophiopogonanone A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins. |
Molecular Weight | 342.34 |
Formula | C19H18O6 |
Cas No. | 74805-92-8 |
Smiles | Cc1c(O)c(C)c2OC[C@@H](Cc3ccc4OCOc4c3)C(=O)c2c1O |
Relative Density. | 1.411g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (175.26 mM), Sonication is recommended. ![]() Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble | |||||||||||||||||||||||||||||||||||
In Vivo Formulation | 10% DMSO+90% (20% SBE-β-CD in Saline): 2.5 mg/mL (7.3 mM) Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.